|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ABCD3-DPYD (FusionGDB2 ID:HG5825TG1806) |
Fusion Gene Summary for ABCD3-DPYD |
Fusion gene summary |
Fusion gene information | Fusion gene name: ABCD3-DPYD | Fusion gene ID: hg5825tg1806 | Hgene | Tgene | Gene symbol | ABCD3 | DPYD | Gene ID | 5825 | 1806 |
Gene name | ATP binding cassette subfamily D member 3 | dihydropyrimidine dehydrogenase | |
Synonyms | ABC43|CBAS5|PMP70|PXMP1|ZWS2 | DHP|DHPDHASE|DPD | |
Cytomap | ('ABCD3')('DPYD') 1p21.3 | 1p21.3 | |
Type of gene | protein-coding | protein-coding | |
Description | ATP-binding cassette sub-family D member 370 kDa peroxisomal membrane proteinATP-binding cassette, sub-family D (ALD), member 3Peroxisomal membrane protein-1 (70kD)dJ824O18.1 (ATP-binding cassette, sub-family D (ALD), member 3 (PMP70, PXMP1))peroxiso | dihydropyrimidine dehydrogenase [NADP(+)]dihydrothymine dehydrogenasedihydrouracil dehydrogenase | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | Q12882 | |
Ensembl transtripts involved in fusion gene | ENST00000484213, ENST00000370214, ENST00000394233, ENST00000454898, ENST00000536817, ENST00000315713, | ||
Fusion gene scores | * DoF score | 6 X 5 X 4=120 | 12 X 12 X 7=1008 |
# samples | 6 | 13 | |
** MAII score | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(13/1008*10)=-2.95491211047146 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ABCD3 [Title/Abstract] AND DPYD [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ABCD3(94956803)-DPYD(97981497), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | ABCD3-DPYD seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ABCD3-DPYD seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ABCD3-DPYD seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ABCD3-DPYD seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ABCD3 | GO:0007031 | peroxisome organization | 9425230 |
Tgene | DPYD | GO:0006210 | thymine catabolic process | 10410956 |
Tgene | DPYD | GO:0006212 | uracil catabolic process | 1512248|18075467 |
Tgene | DPYD | GO:0006214 | thymidine catabolic process | 1512248 |
Fusion gene breakpoints across ABCD3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across DPYD (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-CH-5764-01A | ABCD3 | chr1 | 94956803 | - | DPYD | chr1 | 97981497 | - |
ChimerDB4 | PRAD | TCGA-CH-5764-01A | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
ChimerDB4 | PRAD | TCGA-CH-5764 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
Top |
Fusion Gene ORF analysis for ABCD3-DPYD |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3CDS | ENST00000484213 | ENST00000370192 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
3UTR-intron | ENST00000484213 | ENST00000306031 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
3UTR-intron | ENST00000484213 | ENST00000423006 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
3UTR-intron | ENST00000484213 | ENST00000474241 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000370214 | ENST00000306031 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000370214 | ENST00000423006 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000370214 | ENST00000474241 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000394233 | ENST00000306031 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000394233 | ENST00000423006 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000394233 | ENST00000474241 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000454898 | ENST00000306031 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000454898 | ENST00000423006 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000454898 | ENST00000474241 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000536817 | ENST00000306031 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000536817 | ENST00000423006 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
5CDS-intron | ENST00000536817 | ENST00000474241 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
In-frame | ENST00000370214 | ENST00000370192 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
In-frame | ENST00000394233 | ENST00000370192 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
In-frame | ENST00000454898 | ENST00000370192 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
In-frame | ENST00000536817 | ENST00000370192 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
intron-3CDS | ENST00000315713 | ENST00000370192 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
intron-intron | ENST00000315713 | ENST00000306031 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
intron-intron | ENST00000315713 | ENST00000423006 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
intron-intron | ENST00000315713 | ENST00000474241 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000394233 | ABCD3 | chr1 | 94956803 | + | ENST00000370192 | DPYD | chr1 | 97981497 | - | 3945 | 1158 | 102 | 2711 | 869 |
ENST00000454898 | ABCD3 | chr1 | 94956803 | + | ENST00000370192 | DPYD | chr1 | 97981497 | - | 4311 | 1524 | 66 | 3077 | 1003 |
ENST00000536817 | ABCD3 | chr1 | 94956803 | + | ENST00000370192 | DPYD | chr1 | 97981497 | - | 4200 | 1413 | 132 | 2966 | 944 |
ENST00000370214 | ABCD3 | chr1 | 94956803 | + | ENST00000370192 | DPYD | chr1 | 97981497 | - | 4197 | 1410 | 24 | 2963 | 979 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000394233 | ENST00000370192 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - | 0.0001108 | 0.99988914 |
ENST00000454898 | ENST00000370192 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - | 0.000132643 | 0.9998673 |
ENST00000536817 | ENST00000370192 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - | 0.0002146 | 0.99978536 |
ENST00000370214 | ENST00000370192 | ABCD3 | chr1 | 94956803 | + | DPYD | chr1 | 97981497 | - | 6.29E-05 | 0.99993706 |
Top |
Fusion Genomic Features for ABCD3-DPYD |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for ABCD3-DPYD |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:94956803/chr1:97981497) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | DPYD |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Involved in pyrimidine base degradation. Catalyzes the reduction of uracil and thymine. Also involved the degradation of the chemotherapeutic drug 5-fluorouracil. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000370214 | + | 16 | 23 | 85_372 | 462 | 660.0 | Domain | ABC transmembrane type-1 |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000370214 | + | 16 | 23 | 1_124 | 462 | 660.0 | Region | Note=Targeting to peroxisomes |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000394233 | + | 12 | 19 | 1_124 | 352 | 550.0 | Region | Note=Targeting to peroxisomes |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000370214 | + | 16 | 23 | 126_146 | 462 | 660.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000370214 | + | 16 | 23 | 224_244 | 462 | 660.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000370214 | + | 16 | 23 | 313_333 | 462 | 660.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000370214 | + | 16 | 23 | 84_104 | 462 | 660.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000394233 | + | 12 | 19 | 126_146 | 352 | 550.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000394233 | + | 12 | 19 | 224_244 | 352 | 550.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000394233 | + | 12 | 19 | 313_333 | 352 | 550.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000394233 | + | 12 | 19 | 84_104 | 352 | 550.0 | Transmembrane | Helical |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 944_976 | 508 | 1026.0 | Domain | 4Fe-4S ferredoxin-type 2 | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 978_1007 | 508 | 1026.0 | Domain | 4Fe-4S ferredoxin-type 3 | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 574_575 | 508 | 1026.0 | Nucleotide binding | FMN | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 793_795 | 508 | 1026.0 | Nucleotide binding | FMN | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 816_817 | 508 | 1026.0 | Nucleotide binding | FMN | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 668_670 | 508 | 1026.0 | Region | Substrate binding | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 736_737 | 508 | 1026.0 | Region | Substrate binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000315713 | + | 1 | 9 | 440_659 | 0 | 237.0 | Domain | ABC transporter |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000315713 | + | 1 | 9 | 85_372 | 0 | 237.0 | Domain | ABC transmembrane type-1 |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000370214 | + | 16 | 23 | 440_659 | 462 | 660.0 | Domain | ABC transporter |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000394233 | + | 12 | 19 | 440_659 | 352 | 550.0 | Domain | ABC transporter |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000394233 | + | 12 | 19 | 85_372 | 352 | 550.0 | Domain | ABC transmembrane type-1 |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000315713 | + | 1 | 9 | 473_480 | 0 | 237.0 | Nucleotide binding | ATP |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000370214 | + | 16 | 23 | 473_480 | 462 | 660.0 | Nucleotide binding | ATP |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000394233 | + | 12 | 19 | 473_480 | 352 | 550.0 | Nucleotide binding | ATP |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000315713 | + | 1 | 9 | 1_124 | 0 | 237.0 | Region | Note=Targeting to peroxisomes |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000315713 | + | 1 | 9 | 126_146 | 0 | 237.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000315713 | + | 1 | 9 | 224_244 | 0 | 237.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000315713 | + | 1 | 9 | 313_333 | 0 | 237.0 | Transmembrane | Helical |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000315713 | + | 1 | 9 | 84_104 | 0 | 237.0 | Transmembrane | Helical |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 69_100 | 508 | 1026.0 | Domain | 4Fe-4S ferredoxin-type 1 | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 194_198 | 508 | 1026.0 | Nucleotide binding | FAD | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 218_226 | 508 | 1026.0 | Nucleotide binding | FAD | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 340_343 | 508 | 1026.0 | Nucleotide binding | NADP | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 364_365 | 508 | 1026.0 | Nucleotide binding | NADP | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 437_439 | 508 | 1026.0 | Nucleotide binding | NADP | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 480_489 | 508 | 1026.0 | Nucleotide binding | FAD | |
Tgene | DPYD | chr1:94956803 | chr1:97981497 | ENST00000370192 | 11 | 23 | 481_487 | 508 | 1026.0 | Nucleotide binding | NADP |
Top |
Fusion Gene Sequence for ABCD3-DPYD |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>325_325_1_ABCD3-DPYD_ABCD3_chr1_94956803_ENST00000370214_DPYD_chr1_97981497_ENST00000370192_length(transcript)=4197nt_BP=1410nt CGGCTCGCTGGTACCGGCAGTGCCATGGCGGCCTTCAGCAAGTACTTGACGGCGCGAAACTCCTCGCTGGCTGGTGCCGCGTTCCTGCTG CTCTGCCTGCTCCACAAGCGGCGCCGCGCCCTCGGCCTGCACGGTAAGAAAAGTGGAAAACCACCATTACAGAACAATGAGAAAGAGGGG AAAAAGGAGCGAGCTGTGGTGGACAAGGTGTTTTTCTCAAGGCTCATACAGATTCTGAAAATCATGGTCCCTAGAACATTTTGTAAAGAG ACAGGTTACTTGGTACTTATTGCTGTTATGCTGGTGTCTCGAACATATTGTGATGTTTGGATGATTCAAAATGGGACACTAATTGAAAGT GGTATCATTGGTCGTAGCAGGAAAGATTTCAAGAGATACTTACTCAACTTCATCGCTGCCATGCCTCTTATCTCTCTGGTTAATAACTTC TTGAAGTATGGGTTAAATGAGCTTAAACTGTGCTTCCGAGTAAGGCTCACTAAATACCTCTATGAGGAGTATCTTCAAGCTTTCACATAT TATAAAATGGGGAATCTGGACAACAGAATAGCTAATCCAGACCAGCTGCTTACACAAGATGTAGAAAAATTTTGTAACAGTGTAGTCGAT CTGTATTCAAATCTTAGTAAGCCATTTTTAGACATAGTTTTGTATATCTTTAAGTTAACGAGTGCAATTGGAGCTCAGGGCCCAGCGAGC ATGATGGCCTACTTGGTTGTTTCTGGGCTATTCCTAACTCGACTTCGAAGACCCATTGGTAAGATGACAATAACTGAGCAAAAGTATGAA GGAGAATATAGATATGTTAATTCTCGGCTCATCACAAACAGTGAAGAAATTGCCTTTTACAATGGGAATAAAAGAGAAAAGCAGACAGTC CACTCAGTCTTCCGAAAACTGGTGGAACACCTACATAATTTCATTTTGTTTCGGTTTTCAATGGGCTTCATTGATAGTATTATTGCCAAA TACCTTGCCACTGTTGTTGGTTACCTAGTTGTCAGTCGCCCTTTCTTAGATTTGTCTCATCCTCGACATCTCAAGAGTACACATTCGGAA CTTCTAGAGGATTACTACCAAAGTGGAAGAATGCTTTTGCGAATGTCTCAAGCTCTGGGTCGAATAGTTTTGGCTGGGCGTGAAATGACT AGATTGGCCGGTTTTACTGCTCGGATTACAGAATTAATGCAAGTACTGAAGGATTTAAATCATGGCAAATATGAGCGCACAATGGTCTCA CAACAGGAAAAGGGTATTGAAGGAGTACAAGTCATTCCCTTGATACCTGGTGCTGGAGAAATCATTATTGCAGATAACATTATAAAGTTT GATCATGTTCCTTTAGCAACGCCAAATGGAGATGTTTTGATCCGAGACCTTAATTTTGAATCACAATATGGAGCTTCCGTTTCTGCCAAG CCTGAACTACCCCTCTTTTACACTCCTATTGATCTGGTGGACATTAGTGTAGAAATGGCCGGATTGAAGTTTATAAATCCTTTTGGTCTT GCTAGCGCAACTCCAGCCACCAGCACATCAATGATTCGAAGAGCTTTTGAAGCTGGATGGGGTTTTGCCCTCACCAAAACTTTCTCTCTT GATAAGGACATTGTGACAAATGTTTCCCCCAGAATCATCCGGGGAACCACCTCTGGCCCCATGTATGGCCCTGGACAAAGCTCCTTTCTG AATATTGAGCTCATCAGTGAGAAAACGGCTGCATATTGGTGTCAAAGTGTCACTGAACTAAAGGCTGACTTTCCAGACAACATTGTGATT GCTAGCATTATGTGCAGTTACAATAAAAATGACTGGACGGAACTTGCCAAGAAGTCTGAGGATTCTGGAGCAGATGCCCTGGAGTTAAAT TTATCATGTCCACATGGCATGGGAGAAAGAGGAATGGGCCTGGCCTGTGGGCAGGATCCAGAGCTGGTGCGGAACATCTGCCGCTGGGTT AGGCAAGCTGTTCAGATTCCTTTTTTTGCCAAGCTGACCCCAAATGTCACTGATATTGTGAGCATCGCAAGAGCTGCAAAGGAAGGTGGT GCCAATGGCGTTACAGCCACCAACACTGTCTCAGGTCTGATGGGATTAAAATCTGATGGCACACCTTGGCCAGCAGTGGGGATTGCAAAG CGAACTACATATGGAGGAGTGTCTGGGACAGCAATCAGACCTATTGCTTTGAGAGCTGTGACCTCCATTGCTCGTGCTCTGCCTGGATTT CCCATTTTGGCTACTGGTGGAATTGACTCTGCTGAAAGTGGTCTTCAGTTTCTCCATAGTGGTGCTTCCGTCCTCCAGGTATGCAGTGCC ATTCAGAATCAGGATTTCACTGTGATCGAAGACTACTGCACTGGCCTCAAAGCCCTGCTTTATCTGAAAAGCATTGAAGAACTACAAGAC TGGGATGGACAGAGTCCAGCTACTGTGAGTCACCAGAAAGGGAAACCAGTTCCACGTATAGCTGAACTCATGGACAAGAAACTGCCAAGT TTTGGACCTTATCTGGAACAGCGCAAGAAAATCATAGCAGAAAACAAGATTAGACTGAAAGAACAAAATGTAGCTTTTTCACCACTTAAG AGAAACTGTTTTATCCCCAAAAGGCCTATTCCTACCATCAAGGATGTAATAGGAAAAGCACTGCAGTACCTTGGAACATTTGGTGAATTG AGCAACGTAGAGCAAGTTGTGGCTATGATTGATGAAGAAATGTGTATCAACTGTGGTAAATGCTACATGACCTGTAATGATTCTGGCTAC CAGGCTATACAGTTTGATCCAGAAACCCACCTGCCCACCATAACCGACACTTGTACAGGCTGTACTCTGTGTCTCAGTGTTTGCCCTATT GTCGACTGCATCAAAATGGTTTCCAGGACAACACCTTATGAACCAAAGAGAGGCGTACCCTTATCTGTGAATCCGGTGTGTTAAGGTGAT TTGTGAAACAGTTGCTGTGAACTTTCATGTCACCTACATATGCTGATCTTTTAAAATCATGATCCTTGTGTTCAGCTCTTTCCAAATTAA AACAAATATACATTTTCTAAATAAAAATATGTAATTTCAAAATACATTTGTAAGTGTAAAAAATGTCTCATGTCAATGACCATTCAATTA GTGGTCATAAAATAGAATAATTCTTTTCTGAGGATAGTAGTTAAATAACTGTGTGGCAGTTAATTGGATGTTCACTGCCAGTTGTCTTAT GTGAAAAATTAACTTTTTTGTGGCAATTAGTGTGACAGTTTCCAAATTGCCCTATGCTGTGCTCCATATTTGATTTCTAATTGTAAGTGA AATTAAGCATTTTGAAACAAAGTACTCTTTAACATACAAGAAAATGTATCCAAGGAAACATTTTATCATTAAAAATTACCTTTAATTTTA ATGCTGTTTCTAAGAAAATGTAGTTAGCTCCATAAAGTACAAATGAAGAAAGTCAAAAAATTATTTGCTATGGCAGGATAAGAAAGCCTA AAATTGAGTTTGTAGAACTTTATTAAGTAAAATCCCCTTCGCTGAAATTGCTTATTTTTGGTGTTGGATAGAGGATAGGGAGAATATTTA CTAACTAAATACCATTCACTACTCATGCGTGAGATGGGTGTACAAACTCATCCTCTTTTAATGGCATTTCTCTTTAAACTATGTTCCTAA CAAAATGAGATGATAGGATAGATCCTGGTTACCACTCTTTTGCTGTGCACATACGGGCTCTGACTGGTTTTAATAGTCACCTTCATGATT ATAGCAACTAATGTTTGAACAAAGCTCAAAGTATGCAATGCTTCATTATTCAAGAATGAAAAATATAATGTTGATAATATATATTAAGTG TGCCAAATCAGTTTGACTACTCTCTGTTTTAGTGTTTATGTTTAAAAGAAATATATTTTTTGTTATTATTAGATAATATTTTTGTATTTC TCTATTTTCATAATCAGTAAATAGTGTCATATAAACTCATTTATCTCCTCTTCATGGCATCTTCAATATGAATCTATAAGTAGTAAATCA GAAAGTAACAATCTATGGCTTATTTCTATGACAAATTCAAGAGCTAGAAAAATAAAATGTTTCATTATGCACTTTTAGAAATGCATATTT >325_325_1_ABCD3-DPYD_ABCD3_chr1_94956803_ENST00000370214_DPYD_chr1_97981497_ENST00000370192_length(amino acids)=979AA_BP=462 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGKKSGKPPLQNNEKEGKKERAVVDKVFFSRLIQILKIMVPRTFCKETGYLVLIA VMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRYLLNFIAAMPLISLVNNFLKYGLNELKLCFRVRLTKYLYEEYLQAFTYYKMGNLDN RIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIVLYIFKLTSAIGAQGPASMMAYLVVSGLFLTRLRRPIGKMTITEQKYEGEYRYVNS RLITNSEEIAFYNGNKREKQTVHSVFRKLVEHLHNFILFRFSMGFIDSIIAKYLATVVGYLVVSRPFLDLSHPRHLKSTHSELLEDYYQS GRMLLRMSQALGRIVLAGREMTRLAGFTARITELMQVLKDLNHGKYERTMVSQQEKGIEGVQVIPLIPGAGEIIIADNIIKFDHVPLATP NGDVLIRDLNFESQYGASVSAKPELPLFYTPIDLVDISVEMAGLKFINPFGLASATPATSTSMIRRAFEAGWGFALTKTFSLDKDIVTNV SPRIIRGTTSGPMYGPGQSSFLNIELISEKTAAYWCQSVTELKADFPDNIVIASIMCSYNKNDWTELAKKSEDSGADALELNLSCPHGMG ERGMGLACGQDPELVRNICRWVRQAVQIPFFAKLTPNVTDIVSIARAAKEGGANGVTATNTVSGLMGLKSDGTPWPAVGIAKRTTYGGVS GTAIRPIALRAVTSIARALPGFPILATGGIDSAESGLQFLHSGASVLQVCSAIQNQDFTVIEDYCTGLKALLYLKSIEELQDWDGQSPAT VSHQKGKPVPRIAELMDKKLPSFGPYLEQRKKIIAENKIRLKEQNVAFSPLKRNCFIPKRPIPTIKDVIGKALQYLGTFGELSNVEQVVA -------------------------------------------------------------- >325_325_2_ABCD3-DPYD_ABCD3_chr1_94956803_ENST00000394233_DPYD_chr1_97981497_ENST00000370192_length(transcript)=3945nt_BP=1158nt CTCTGCTCTCCTCCCAGTCTCCCCCGCGCTGCGTGCAGTAAGGTAGCCGCCGCCGCCGCCGCCGCCGCGTCCCCTCGCCGGCTCGCTGGT ACCGGCAGTGCCATGGCGGCCTTCAGCAAGTACTTGACGGCGCGAAACTCCTCGCTGGCTGGTGCCGCGTTCCTGCTGCTCTGCCTGCTC CACAAGCGGCGCCGCGCCCTCGGCCTGCACGGTAAGAAAAGTGGAAAACCACCATTACAGAACAATGAGAAAGAGGGGAAAAAGGAGCGA GCTGTGGTGGACAAGGTGTTTTTCTCAAGGCTCATACAGATTCTGAAAATCATGGTCCCTAGAACATTTTGTAAAGAGACAGGTTACTTG GTACTTATTGCTGTTATGCTGGTGTCTCGAACATATTGTGATGTTTGGATGATTCAAAATGGGACACTAATTGAAAGTGGTATCATTGGT CGTAGCAGGAAAGATTTCAAGAGATACTTACTCAACTTCATCGCTGCCATGCCTCTTATCTCTCTGGTTAATAACTTCTTGAAGTATGGG TTAAATGAGCTTAAACTGTGCTTCCGAGTAAGGCTCACTAAATACCTCTATGAGGAGTATCTTCAAGCTTTCACATATTATAAAATGGGG AATCTGGACAACAGAATAGCTAATCCAGACCAGCTGCTTACACAAGATGTAGAAAAATTTTGTAACAGTGTAGTCGATCTGTATTCAAAT CTTAGTAAGCCATTTTTAGACATAGTTTTGTATATCTTTAAGTTAACGAGTGCAATTGGAGCTCAGGGCCCAGCGAGCATGATGGCCTAC TTGGTTGTTTCTGGGCTATTCCTAACTCGACTTCGAAGACCCATTGGTAAGATGACAATAACTGAGCAAAAGTATGAAGGAGAATATAGA TATGTTAATTCTCGGCTCATCACAAACAGTTTTACTGCTCGGATTACAGAATTAATGCAAGTACTGAAGGATTTAAATCATGGCAAATAT GAGCGCACAATGGTCTCACAACAGGAAAAGGGTATTGAAGGAGTACAAGTCATTCCCTTGATACCTGGTGCTGGAGAAATCATTATTGCA GATAACATTATAAAGTTTGATCATGTTCCTTTAGCAACGCCAAATGGAGATGTTTTGATCCGAGACCTTAATTTTGAATCACAATATGGA GCTTCCGTTTCTGCCAAGCCTGAACTACCCCTCTTTTACACTCCTATTGATCTGGTGGACATTAGTGTAGAAATGGCCGGATTGAAGTTT ATAAATCCTTTTGGTCTTGCTAGCGCAACTCCAGCCACCAGCACATCAATGATTCGAAGAGCTTTTGAAGCTGGATGGGGTTTTGCCCTC ACCAAAACTTTCTCTCTTGATAAGGACATTGTGACAAATGTTTCCCCCAGAATCATCCGGGGAACCACCTCTGGCCCCATGTATGGCCCT GGACAAAGCTCCTTTCTGAATATTGAGCTCATCAGTGAGAAAACGGCTGCATATTGGTGTCAAAGTGTCACTGAACTAAAGGCTGACTTT CCAGACAACATTGTGATTGCTAGCATTATGTGCAGTTACAATAAAAATGACTGGACGGAACTTGCCAAGAAGTCTGAGGATTCTGGAGCA GATGCCCTGGAGTTAAATTTATCATGTCCACATGGCATGGGAGAAAGAGGAATGGGCCTGGCCTGTGGGCAGGATCCAGAGCTGGTGCGG AACATCTGCCGCTGGGTTAGGCAAGCTGTTCAGATTCCTTTTTTTGCCAAGCTGACCCCAAATGTCACTGATATTGTGAGCATCGCAAGA GCTGCAAAGGAAGGTGGTGCCAATGGCGTTACAGCCACCAACACTGTCTCAGGTCTGATGGGATTAAAATCTGATGGCACACCTTGGCCA GCAGTGGGGATTGCAAAGCGAACTACATATGGAGGAGTGTCTGGGACAGCAATCAGACCTATTGCTTTGAGAGCTGTGACCTCCATTGCT CGTGCTCTGCCTGGATTTCCCATTTTGGCTACTGGTGGAATTGACTCTGCTGAAAGTGGTCTTCAGTTTCTCCATAGTGGTGCTTCCGTC CTCCAGGTATGCAGTGCCATTCAGAATCAGGATTTCACTGTGATCGAAGACTACTGCACTGGCCTCAAAGCCCTGCTTTATCTGAAAAGC ATTGAAGAACTACAAGACTGGGATGGACAGAGTCCAGCTACTGTGAGTCACCAGAAAGGGAAACCAGTTCCACGTATAGCTGAACTCATG GACAAGAAACTGCCAAGTTTTGGACCTTATCTGGAACAGCGCAAGAAAATCATAGCAGAAAACAAGATTAGACTGAAAGAACAAAATGTA GCTTTTTCACCACTTAAGAGAAACTGTTTTATCCCCAAAAGGCCTATTCCTACCATCAAGGATGTAATAGGAAAAGCACTGCAGTACCTT GGAACATTTGGTGAATTGAGCAACGTAGAGCAAGTTGTGGCTATGATTGATGAAGAAATGTGTATCAACTGTGGTAAATGCTACATGACC TGTAATGATTCTGGCTACCAGGCTATACAGTTTGATCCAGAAACCCACCTGCCCACCATAACCGACACTTGTACAGGCTGTACTCTGTGT CTCAGTGTTTGCCCTATTGTCGACTGCATCAAAATGGTTTCCAGGACAACACCTTATGAACCAAAGAGAGGCGTACCCTTATCTGTGAAT CCGGTGTGTTAAGGTGATTTGTGAAACAGTTGCTGTGAACTTTCATGTCACCTACATATGCTGATCTTTTAAAATCATGATCCTTGTGTT CAGCTCTTTCCAAATTAAAACAAATATACATTTTCTAAATAAAAATATGTAATTTCAAAATACATTTGTAAGTGTAAAAAATGTCTCATG TCAATGACCATTCAATTAGTGGTCATAAAATAGAATAATTCTTTTCTGAGGATAGTAGTTAAATAACTGTGTGGCAGTTAATTGGATGTT CACTGCCAGTTGTCTTATGTGAAAAATTAACTTTTTTGTGGCAATTAGTGTGACAGTTTCCAAATTGCCCTATGCTGTGCTCCATATTTG ATTTCTAATTGTAAGTGAAATTAAGCATTTTGAAACAAAGTACTCTTTAACATACAAGAAAATGTATCCAAGGAAACATTTTATCATTAA AAATTACCTTTAATTTTAATGCTGTTTCTAAGAAAATGTAGTTAGCTCCATAAAGTACAAATGAAGAAAGTCAAAAAATTATTTGCTATG GCAGGATAAGAAAGCCTAAAATTGAGTTTGTAGAACTTTATTAAGTAAAATCCCCTTCGCTGAAATTGCTTATTTTTGGTGTTGGATAGA GGATAGGGAGAATATTTACTAACTAAATACCATTCACTACTCATGCGTGAGATGGGTGTACAAACTCATCCTCTTTTAATGGCATTTCTC TTTAAACTATGTTCCTAACAAAATGAGATGATAGGATAGATCCTGGTTACCACTCTTTTGCTGTGCACATACGGGCTCTGACTGGTTTTA ATAGTCACCTTCATGATTATAGCAACTAATGTTTGAACAAAGCTCAAAGTATGCAATGCTTCATTATTCAAGAATGAAAAATATAATGTT GATAATATATATTAAGTGTGCCAAATCAGTTTGACTACTCTCTGTTTTAGTGTTTATGTTTAAAAGAAATATATTTTTTGTTATTATTAG ATAATATTTTTGTATTTCTCTATTTTCATAATCAGTAAATAGTGTCATATAAACTCATTTATCTCCTCTTCATGGCATCTTCAATATGAA TCTATAAGTAGTAAATCAGAAAGTAACAATCTATGGCTTATTTCTATGACAAATTCAAGAGCTAGAAAAATAAAATGTTTCATTATGCAC >325_325_2_ABCD3-DPYD_ABCD3_chr1_94956803_ENST00000394233_DPYD_chr1_97981497_ENST00000370192_length(amino acids)=869AA_BP=352 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGKKSGKPPLQNNEKEGKKERAVVDKVFFSRLIQILKIMVPRTFCKETGYLVLIA VMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRYLLNFIAAMPLISLVNNFLKYGLNELKLCFRVRLTKYLYEEYLQAFTYYKMGNLDN RIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIVLYIFKLTSAIGAQGPASMMAYLVVSGLFLTRLRRPIGKMTITEQKYEGEYRYVNS RLITNSFTARITELMQVLKDLNHGKYERTMVSQQEKGIEGVQVIPLIPGAGEIIIADNIIKFDHVPLATPNGDVLIRDLNFESQYGASVS AKPELPLFYTPIDLVDISVEMAGLKFINPFGLASATPATSTSMIRRAFEAGWGFALTKTFSLDKDIVTNVSPRIIRGTTSGPMYGPGQSS FLNIELISEKTAAYWCQSVTELKADFPDNIVIASIMCSYNKNDWTELAKKSEDSGADALELNLSCPHGMGERGMGLACGQDPELVRNICR WVRQAVQIPFFAKLTPNVTDIVSIARAAKEGGANGVTATNTVSGLMGLKSDGTPWPAVGIAKRTTYGGVSGTAIRPIALRAVTSIARALP GFPILATGGIDSAESGLQFLHSGASVLQVCSAIQNQDFTVIEDYCTGLKALLYLKSIEELQDWDGQSPATVSHQKGKPVPRIAELMDKKL PSFGPYLEQRKKIIAENKIRLKEQNVAFSPLKRNCFIPKRPIPTIKDVIGKALQYLGTFGELSNVEQVVAMIDEEMCINCGKCYMTCNDS -------------------------------------------------------------- >325_325_3_ABCD3-DPYD_ABCD3_chr1_94956803_ENST00000454898_DPYD_chr1_97981497_ENST00000370192_length(transcript)=4311nt_BP=1524nt AGTAAGGTAGCCGCCGCCGCCGCCGCCGCCGCGTCCCCTCGCCGGCTCGCTGGTACCGGCAGTGCCATGGCGGCCTTCAGCAAGTACTTG ACGGCGCGAAACTCCTCGCTGGCTGGTGCCGCGTTCCTGCTGCTCTGCCTGCTCCACAAGCGGCGCCGCGCCCTCGGCCTGCACGGGTAT TTCATGGAAACTTGGAGAGAGAAAAGTGATGAAGTGATGGGAGAGCTGACTGATCATGTGACTCATTGTAAGAAAAGTGGAAAACCACCA TTACAGAACAATGAGAAAGAGGGGAAAAAGGAGCGAGCTGTGGTGGACAAGGTGTTTTTCTCAAGGCTCATACAGATTCTGAAAATCATG GTCCCTAGAACATTTTGTAAAGAGACAGGTTACTTGGTACTTATTGCTGTTATGCTGGTGTCTCGAACATATTGTGATGTTTGGATGATT CAAAATGGGACACTAATTGAAAGTGGTATCATTGGTCGTAGCAGGAAAGATTTCAAGAGATACTTACTCAACTTCATCGCTGCCATGCCT CTTATCTCTCTGGTTAATAACTTCTTGAAGTATGGGTTAAATGAGCTTAAACTGTGCTTCCGAGTAAGGCTCACTAAATACCTCTATGAG GAGTATCTTCAAGCTTTCACATATTATAAAATGGGGAATCTGGACAACAGAATAGCTAATCCAGACCAGCTGCTTACACAAGATGTAGAA AAATTTTGTAACAGTGTAGTCGATCTGTATTCAAATCTTAGTAAGCCATTTTTAGACATAGTTTTGTATATCTTTAAGTTAACGAGTGCA ATTGGAGCTCAGGGCCCAGCGAGCATGATGGCCTACTTGGTTGTTTCTGGGCTATTCCTAACTCGACTTCGAAGACCCATTGGTAAGATG ACAATAACTGAGCAAAAGTATGAAGGAGAATATAGATATGTTAATTCTCGGCTCATCACAAACAGTGAAGAAATTGCCTTTTACAATGGG AATAAAAGAGAAAAGCAGACAGTCCACTCAGTCTTCCGAAAACTGGTGGAACACCTACATAATTTCATTTTGTTTCGGTTTTCAATGGGC TTCATTGATAGTATTATTGCCAAATACCTTGCCACTGTTGTTGGTTACCTAGTTGTCAGTCGCCCTTTCTTAGATTTGTCTCATCCTCGA CATCTCAAGAGTACACATTCGGAACTTCTAGAGGATTACTACCAAAGTGGAAGAATGCTTTTGCGAATGTCTCAAGCTCTGGGTCGAATA GTTTTGGCTGGGCGTGAAATGACTAGATTGGCCGGTTTTACTGCTCGGATTACAGAATTAATGCAAGTACTGAAGGATTTAAATCATGGC AAATATGAGCGCACAATGGTCTCACAACAGGAAAAGGGTATTGAAGGAGTACAAGTCATTCCCTTGATACCTGGTGCTGGAGAAATCATT ATTGCAGATAACATTATAAAGTTTGATCATGTTCCTTTAGCAACGCCAAATGGAGATGTTTTGATCCGAGACCTTAATTTTGAATCACAA TATGGAGCTTCCGTTTCTGCCAAGCCTGAACTACCCCTCTTTTACACTCCTATTGATCTGGTGGACATTAGTGTAGAAATGGCCGGATTG AAGTTTATAAATCCTTTTGGTCTTGCTAGCGCAACTCCAGCCACCAGCACATCAATGATTCGAAGAGCTTTTGAAGCTGGATGGGGTTTT GCCCTCACCAAAACTTTCTCTCTTGATAAGGACATTGTGACAAATGTTTCCCCCAGAATCATCCGGGGAACCACCTCTGGCCCCATGTAT GGCCCTGGACAAAGCTCCTTTCTGAATATTGAGCTCATCAGTGAGAAAACGGCTGCATATTGGTGTCAAAGTGTCACTGAACTAAAGGCT GACTTTCCAGACAACATTGTGATTGCTAGCATTATGTGCAGTTACAATAAAAATGACTGGACGGAACTTGCCAAGAAGTCTGAGGATTCT GGAGCAGATGCCCTGGAGTTAAATTTATCATGTCCACATGGCATGGGAGAAAGAGGAATGGGCCTGGCCTGTGGGCAGGATCCAGAGCTG GTGCGGAACATCTGCCGCTGGGTTAGGCAAGCTGTTCAGATTCCTTTTTTTGCCAAGCTGACCCCAAATGTCACTGATATTGTGAGCATC GCAAGAGCTGCAAAGGAAGGTGGTGCCAATGGCGTTACAGCCACCAACACTGTCTCAGGTCTGATGGGATTAAAATCTGATGGCACACCT TGGCCAGCAGTGGGGATTGCAAAGCGAACTACATATGGAGGAGTGTCTGGGACAGCAATCAGACCTATTGCTTTGAGAGCTGTGACCTCC ATTGCTCGTGCTCTGCCTGGATTTCCCATTTTGGCTACTGGTGGAATTGACTCTGCTGAAAGTGGTCTTCAGTTTCTCCATAGTGGTGCT TCCGTCCTCCAGGTATGCAGTGCCATTCAGAATCAGGATTTCACTGTGATCGAAGACTACTGCACTGGCCTCAAAGCCCTGCTTTATCTG AAAAGCATTGAAGAACTACAAGACTGGGATGGACAGAGTCCAGCTACTGTGAGTCACCAGAAAGGGAAACCAGTTCCACGTATAGCTGAA CTCATGGACAAGAAACTGCCAAGTTTTGGACCTTATCTGGAACAGCGCAAGAAAATCATAGCAGAAAACAAGATTAGACTGAAAGAACAA AATGTAGCTTTTTCACCACTTAAGAGAAACTGTTTTATCCCCAAAAGGCCTATTCCTACCATCAAGGATGTAATAGGAAAAGCACTGCAG TACCTTGGAACATTTGGTGAATTGAGCAACGTAGAGCAAGTTGTGGCTATGATTGATGAAGAAATGTGTATCAACTGTGGTAAATGCTAC ATGACCTGTAATGATTCTGGCTACCAGGCTATACAGTTTGATCCAGAAACCCACCTGCCCACCATAACCGACACTTGTACAGGCTGTACT CTGTGTCTCAGTGTTTGCCCTATTGTCGACTGCATCAAAATGGTTTCCAGGACAACACCTTATGAACCAAAGAGAGGCGTACCCTTATCT GTGAATCCGGTGTGTTAAGGTGATTTGTGAAACAGTTGCTGTGAACTTTCATGTCACCTACATATGCTGATCTTTTAAAATCATGATCCT TGTGTTCAGCTCTTTCCAAATTAAAACAAATATACATTTTCTAAATAAAAATATGTAATTTCAAAATACATTTGTAAGTGTAAAAAATGT CTCATGTCAATGACCATTCAATTAGTGGTCATAAAATAGAATAATTCTTTTCTGAGGATAGTAGTTAAATAACTGTGTGGCAGTTAATTG GATGTTCACTGCCAGTTGTCTTATGTGAAAAATTAACTTTTTTGTGGCAATTAGTGTGACAGTTTCCAAATTGCCCTATGCTGTGCTCCA TATTTGATTTCTAATTGTAAGTGAAATTAAGCATTTTGAAACAAAGTACTCTTTAACATACAAGAAAATGTATCCAAGGAAACATTTTAT CATTAAAAATTACCTTTAATTTTAATGCTGTTTCTAAGAAAATGTAGTTAGCTCCATAAAGTACAAATGAAGAAAGTCAAAAAATTATTT GCTATGGCAGGATAAGAAAGCCTAAAATTGAGTTTGTAGAACTTTATTAAGTAAAATCCCCTTCGCTGAAATTGCTTATTTTTGGTGTTG GATAGAGGATAGGGAGAATATTTACTAACTAAATACCATTCACTACTCATGCGTGAGATGGGTGTACAAACTCATCCTCTTTTAATGGCA TTTCTCTTTAAACTATGTTCCTAACAAAATGAGATGATAGGATAGATCCTGGTTACCACTCTTTTGCTGTGCACATACGGGCTCTGACTG GTTTTAATAGTCACCTTCATGATTATAGCAACTAATGTTTGAACAAAGCTCAAAGTATGCAATGCTTCATTATTCAAGAATGAAAAATAT AATGTTGATAATATATATTAAGTGTGCCAAATCAGTTTGACTACTCTCTGTTTTAGTGTTTATGTTTAAAAGAAATATATTTTTTGTTAT TATTAGATAATATTTTTGTATTTCTCTATTTTCATAATCAGTAAATAGTGTCATATAAACTCATTTATCTCCTCTTCATGGCATCTTCAA TATGAATCTATAAGTAGTAAATCAGAAAGTAACAATCTATGGCTTATTTCTATGACAAATTCAAGAGCTAGAAAAATAAAATGTTTCATT >325_325_3_ABCD3-DPYD_ABCD3_chr1_94956803_ENST00000454898_DPYD_chr1_97981497_ENST00000370192_length(amino acids)=1003AA_BP=486 MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGYFMETWREKSDEVMGELTDHVTHCKKSGKPPLQNNEKEGKKERAVVDKVFFSR LIQILKIMVPRTFCKETGYLVLIAVMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRYLLNFIAAMPLISLVNNFLKYGLNELKLCFRV RLTKYLYEEYLQAFTYYKMGNLDNRIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIVLYIFKLTSAIGAQGPASMMAYLVVSGLFLTR LRRPIGKMTITEQKYEGEYRYVNSRLITNSEEIAFYNGNKREKQTVHSVFRKLVEHLHNFILFRFSMGFIDSIIAKYLATVVGYLVVSRP FLDLSHPRHLKSTHSELLEDYYQSGRMLLRMSQALGRIVLAGREMTRLAGFTARITELMQVLKDLNHGKYERTMVSQQEKGIEGVQVIPL IPGAGEIIIADNIIKFDHVPLATPNGDVLIRDLNFESQYGASVSAKPELPLFYTPIDLVDISVEMAGLKFINPFGLASATPATSTSMIRR AFEAGWGFALTKTFSLDKDIVTNVSPRIIRGTTSGPMYGPGQSSFLNIELISEKTAAYWCQSVTELKADFPDNIVIASIMCSYNKNDWTE LAKKSEDSGADALELNLSCPHGMGERGMGLACGQDPELVRNICRWVRQAVQIPFFAKLTPNVTDIVSIARAAKEGGANGVTATNTVSGLM GLKSDGTPWPAVGIAKRTTYGGVSGTAIRPIALRAVTSIARALPGFPILATGGIDSAESGLQFLHSGASVLQVCSAIQNQDFTVIEDYCT GLKALLYLKSIEELQDWDGQSPATVSHQKGKPVPRIAELMDKKLPSFGPYLEQRKKIIAENKIRLKEQNVAFSPLKRNCFIPKRPIPTIK DVIGKALQYLGTFGELSNVEQVVAMIDEEMCINCGKCYMTCNDSGYQAIQFDPETHLPTITDTCTGCTLCLSVCPIVDCIKMVSRTTPYE -------------------------------------------------------------- >325_325_4_ABCD3-DPYD_ABCD3_chr1_94956803_ENST00000536817_DPYD_chr1_97981497_ENST00000370192_length(transcript)=4200nt_BP=1413nt TAAGGTAGCCGCCGCCGCCGCCGCCGCCGCGTCCCCTCGCCGGCTCGCTGGTACCGGCAGTGCCATGGCGGCCTTCAGCAAGTACTTGAC GGCGCGAAACTCCTCGCTGGCTGGTGCCGCGTTCCTGCTGCTCTGCCTGCTCCACAAGCGGCGCCGCGCCCTCGGCCTGCACGGAAAGAG GGGAAAAAGGAGCGAGCTGTGGTGGACAAGGTGTTTTTCTCAAGGCTCATACAGATTCTGAAAATCATGGTCCCTAGAACATTTTGTAAA GAGACAGGTTACTTGGTACTTATTGCTGTTATGCTGGTGTCTCGAACATATTGTGATGTTTGGATGATTCAAAATGGGACACTAATTGAA AGTGGTATCATTGGTCGTAGCAGGAAAGATTTCAAGAGATACTTACTCAACTTCATCGCTGCCATGCCTCTTATCTCTCTGGTTAATAAC TTCTTGAAGTATGGGTTAAATGAGCTTAAACTGTGCTTCCGAGTAAGGCTCACTAAATACCTCTATGAGGAGTATCTTCAAGCTTTCACA TATTATAAAATGGGGAATCTGGACAACAGAATAGCTAATCCAGACCAGCTGCTTACACAAGATGTAGAAAAATTTTGTAACAGTGTAGTC GATCTGTATTCAAATCTTAGTAAGCCATTTTTAGACATAGTTTTGTATATCTTTAAGTTAACGAGTGCAATTGGAGCTCAGGGCCCAGCG AGCATGATGGCCTACTTGGTTGTTTCTGGGCTATTCCTAACTCGACTTCGAAGACCCATTGGTAAGATGACAATAACTGAGCAAAAGTAT GAAGGAGAATATAGATATGTTAATTCTCGGCTCATCACAAACAGTGAAGAAATTGCCTTTTACAATGGGAATAAAAGAGAAAAGCAGACA GTCCACTCAGTCTTCCGAAAACTGGTGGAACACCTACATAATTTCATTTTGTTTCGGTTTTCAATGGGCTTCATTGATAGTATTATTGCC AAATACCTTGCCACTGTTGTTGGTTACCTAGTTGTCAGTCGCCCTTTCTTAGATTTGTCTCATCCTCGACATCTCAAGAGTACACATTCG GAACTTCTAGAGGATTACTACCAAAGTGGAAGAATGCTTTTGCGAATGTCTCAAGCTCTGGGTCGAATAGTTTTGGCTGGGCGTGAAATG ACTAGATTGGCCGGTTTTACTGCTCGGATTACAGAATTAATGCAAGTACTGAAGGATTTAAATCATGGCAAATATGAGCGCACAATGGTC TCACAACAGGAAAAGGGTATTGAAGGAGTACAAGTCATTCCCTTGATACCTGGTGCTGGAGAAATCATTATTGCAGATAACATTATAAAG TTTGATCATGTTCCTTTAGCAACGCCAAATGGAGATGTTTTGATCCGAGACCTTAATTTTGAATCACAATATGGAGCTTCCGTTTCTGCC AAGCCTGAACTACCCCTCTTTTACACTCCTATTGATCTGGTGGACATTAGTGTAGAAATGGCCGGATTGAAGTTTATAAATCCTTTTGGT CTTGCTAGCGCAACTCCAGCCACCAGCACATCAATGATTCGAAGAGCTTTTGAAGCTGGATGGGGTTTTGCCCTCACCAAAACTTTCTCT CTTGATAAGGACATTGTGACAAATGTTTCCCCCAGAATCATCCGGGGAACCACCTCTGGCCCCATGTATGGCCCTGGACAAAGCTCCTTT CTGAATATTGAGCTCATCAGTGAGAAAACGGCTGCATATTGGTGTCAAAGTGTCACTGAACTAAAGGCTGACTTTCCAGACAACATTGTG ATTGCTAGCATTATGTGCAGTTACAATAAAAATGACTGGACGGAACTTGCCAAGAAGTCTGAGGATTCTGGAGCAGATGCCCTGGAGTTA AATTTATCATGTCCACATGGCATGGGAGAAAGAGGAATGGGCCTGGCCTGTGGGCAGGATCCAGAGCTGGTGCGGAACATCTGCCGCTGG GTTAGGCAAGCTGTTCAGATTCCTTTTTTTGCCAAGCTGACCCCAAATGTCACTGATATTGTGAGCATCGCAAGAGCTGCAAAGGAAGGT GGTGCCAATGGCGTTACAGCCACCAACACTGTCTCAGGTCTGATGGGATTAAAATCTGATGGCACACCTTGGCCAGCAGTGGGGATTGCA AAGCGAACTACATATGGAGGAGTGTCTGGGACAGCAATCAGACCTATTGCTTTGAGAGCTGTGACCTCCATTGCTCGTGCTCTGCCTGGA TTTCCCATTTTGGCTACTGGTGGAATTGACTCTGCTGAAAGTGGTCTTCAGTTTCTCCATAGTGGTGCTTCCGTCCTCCAGGTATGCAGT GCCATTCAGAATCAGGATTTCACTGTGATCGAAGACTACTGCACTGGCCTCAAAGCCCTGCTTTATCTGAAAAGCATTGAAGAACTACAA GACTGGGATGGACAGAGTCCAGCTACTGTGAGTCACCAGAAAGGGAAACCAGTTCCACGTATAGCTGAACTCATGGACAAGAAACTGCCA AGTTTTGGACCTTATCTGGAACAGCGCAAGAAAATCATAGCAGAAAACAAGATTAGACTGAAAGAACAAAATGTAGCTTTTTCACCACTT AAGAGAAACTGTTTTATCCCCAAAAGGCCTATTCCTACCATCAAGGATGTAATAGGAAAAGCACTGCAGTACCTTGGAACATTTGGTGAA TTGAGCAACGTAGAGCAAGTTGTGGCTATGATTGATGAAGAAATGTGTATCAACTGTGGTAAATGCTACATGACCTGTAATGATTCTGGC TACCAGGCTATACAGTTTGATCCAGAAACCCACCTGCCCACCATAACCGACACTTGTACAGGCTGTACTCTGTGTCTCAGTGTTTGCCCT ATTGTCGACTGCATCAAAATGGTTTCCAGGACAACACCTTATGAACCAAAGAGAGGCGTACCCTTATCTGTGAATCCGGTGTGTTAAGGT GATTTGTGAAACAGTTGCTGTGAACTTTCATGTCACCTACATATGCTGATCTTTTAAAATCATGATCCTTGTGTTCAGCTCTTTCCAAAT TAAAACAAATATACATTTTCTAAATAAAAATATGTAATTTCAAAATACATTTGTAAGTGTAAAAAATGTCTCATGTCAATGACCATTCAA TTAGTGGTCATAAAATAGAATAATTCTTTTCTGAGGATAGTAGTTAAATAACTGTGTGGCAGTTAATTGGATGTTCACTGCCAGTTGTCT TATGTGAAAAATTAACTTTTTTGTGGCAATTAGTGTGACAGTTTCCAAATTGCCCTATGCTGTGCTCCATATTTGATTTCTAATTGTAAG TGAAATTAAGCATTTTGAAACAAAGTACTCTTTAACATACAAGAAAATGTATCCAAGGAAACATTTTATCATTAAAAATTACCTTTAATT TTAATGCTGTTTCTAAGAAAATGTAGTTAGCTCCATAAAGTACAAATGAAGAAAGTCAAAAAATTATTTGCTATGGCAGGATAAGAAAGC CTAAAATTGAGTTTGTAGAACTTTATTAAGTAAAATCCCCTTCGCTGAAATTGCTTATTTTTGGTGTTGGATAGAGGATAGGGAGAATAT TTACTAACTAAATACCATTCACTACTCATGCGTGAGATGGGTGTACAAACTCATCCTCTTTTAATGGCATTTCTCTTTAAACTATGTTCC TAACAAAATGAGATGATAGGATAGATCCTGGTTACCACTCTTTTGCTGTGCACATACGGGCTCTGACTGGTTTTAATAGTCACCTTCATG ATTATAGCAACTAATGTTTGAACAAAGCTCAAAGTATGCAATGCTTCATTATTCAAGAATGAAAAATATAATGTTGATAATATATATTAA GTGTGCCAAATCAGTTTGACTACTCTCTGTTTTAGTGTTTATGTTTAAAAGAAATATATTTTTTGTTATTATTAGATAATATTTTTGTAT TTCTCTATTTTCATAATCAGTAAATAGTGTCATATAAACTCATTTATCTCCTCTTCATGGCATCTTCAATATGAATCTATAAGTAGTAAA TCAGAAAGTAACAATCTATGGCTTATTTCTATGACAAATTCAAGAGCTAGAAAAATAAAATGTTTCATTATGCACTTTTAGAAATGCATA >325_325_4_ABCD3-DPYD_ABCD3_chr1_94956803_ENST00000536817_DPYD_chr1_97981497_ENST00000370192_length(amino acids)=944AA_BP=427 MPAPQAAPRPRPARKEGKKERAVVDKVFFSRLIQILKIMVPRTFCKETGYLVLIAVMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRY LLNFIAAMPLISLVNNFLKYGLNELKLCFRVRLTKYLYEEYLQAFTYYKMGNLDNRIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIV LYIFKLTSAIGAQGPASMMAYLVVSGLFLTRLRRPIGKMTITEQKYEGEYRYVNSRLITNSEEIAFYNGNKREKQTVHSVFRKLVEHLHN FILFRFSMGFIDSIIAKYLATVVGYLVVSRPFLDLSHPRHLKSTHSELLEDYYQSGRMLLRMSQALGRIVLAGREMTRLAGFTARITELM QVLKDLNHGKYERTMVSQQEKGIEGVQVIPLIPGAGEIIIADNIIKFDHVPLATPNGDVLIRDLNFESQYGASVSAKPELPLFYTPIDLV DISVEMAGLKFINPFGLASATPATSTSMIRRAFEAGWGFALTKTFSLDKDIVTNVSPRIIRGTTSGPMYGPGQSSFLNIELISEKTAAYW CQSVTELKADFPDNIVIASIMCSYNKNDWTELAKKSEDSGADALELNLSCPHGMGERGMGLACGQDPELVRNICRWVRQAVQIPFFAKLT PNVTDIVSIARAAKEGGANGVTATNTVSGLMGLKSDGTPWPAVGIAKRTTYGGVSGTAIRPIALRAVTSIARALPGFPILATGGIDSAES GLQFLHSGASVLQVCSAIQNQDFTVIEDYCTGLKALLYLKSIEELQDWDGQSPATVSHQKGKPVPRIAELMDKKLPSFGPYLEQRKKIIA ENKIRLKEQNVAFSPLKRNCFIPKRPIPTIKDVIGKALQYLGTFGELSNVEQVVAMIDEEMCINCGKCYMTCNDSGYQAIQFDPETHLPT -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ABCD3-DPYD |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000370214 | + | 16 | 23 | 1_199 | 462.0 | 660.0 | PEX19 |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000394233 | + | 12 | 19 | 1_199 | 352.0 | 550.0 | PEX19 |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | ABCD3 | chr1:94956803 | chr1:97981497 | ENST00000315713 | + | 1 | 9 | 1_199 | 0.0 | 237.0 | PEX19 |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ABCD3-DPYD |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | DPYD | Q12882 | DB03147 | Flavin adenine dinucleotide | Small molecule | Approved | |
Tgene | DPYD | Q12882 | DB09257 | Gimeracil | Inhibitor | Small molecule | Approved |
Tgene | DPYD | Q12882 | DB03247 | Flavin mononucleotide | Small molecule | Approved|Investigational | |
Tgene | DPYD | Q12882 | DB09327 | Tegafur-uracil | Antagonist | Small molecule | Approved|Investigational |
Top |
Related Diseases for ABCD3-DPYD |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ABCD3 | C0009402 | Colorectal Carcinoma | 1 | CTD_human |
Hgene | ABCD3 | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Hgene | ABCD3 | C0043459 | Zellweger Syndrome | 1 | CTD_human |
Hgene | ABCD3 | C0751594 | Zellweger-Like Syndrome | 1 | CTD_human |
Hgene | ABCD3 | C3658299 | Zellweger Spectrum | 1 | CTD_human |
Hgene | ABCD3 | C4225390 | BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5 | 1 | CTD_human;GENOMICS_ENGLAND |
Tgene | C1959620 | Dihydropyrimidine Dehydrogenase Deficiency | 7 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C0009402 | Colorectal Carcinoma | 5 | CTD_human | |
Tgene | C0009404 | Colorectal Neoplasms | 5 | CTD_human | |
Tgene | C0024623 | Malignant neoplasm of stomach | 3 | CTD_human | |
Tgene | C0038356 | Stomach Neoplasms | 3 | CTD_human | |
Tgene | C1708349 | Hereditary Diffuse Gastric Cancer | 3 | CTD_human | |
Tgene | C0030297 | Pancreatic Neoplasm | 2 | CTD_human | |
Tgene | C0034139 | Purine-Pyrimidine Metabolism, Inborn Errors | 2 | CTD_human | |
Tgene | C0036341 | Schizophrenia | 2 | CTD_human | |
Tgene | C0346647 | Malignant neoplasm of pancreas | 2 | CTD_human | |
Tgene | C1510586 | Autism Spectrum Disorders | 2 | CTD_human | |
Tgene | C3495551 | Dihydropyrimidinuria | 2 | CTD_human | |
Tgene | C4304578 | 1p21.3 microdeletion syndrome | 2 | ORPHANET | |
Tgene | C0004352 | Autistic Disorder | 1 | CTD_human | |
Tgene | C0006142 | Malignant neoplasm of breast | 1 | CTD_human | |
Tgene | C0007102 | Malignant tumor of colon | 1 | CTD_human | |
Tgene | C0009375 | Colonic Neoplasms | 1 | CTD_human | |
Tgene | C0018671 | Head and Neck Neoplasms | 1 | CTD_human | |
Tgene | C0018675 | Head Neoplasms | 1 | CTD_human | |
Tgene | C0023012 | Language Delay | 1 | CTD_human | |
Tgene | C0023014 | Language Development Disorders | 1 | CTD_human | |
Tgene | C0024121 | Lung Neoplasms | 1 | CTD_human | |
Tgene | C0027533 | Neck Neoplasms | 1 | CTD_human | |
Tgene | C0027627 | Neoplasm Metastasis | 1 | CTD_human | |
Tgene | C0027765 | nervous system disorder | 1 | CTD_human | |
Tgene | C0027947 | Neutropenia | 1 | CTD_human | |
Tgene | C0028754 | Obesity | 1 | CTD_human | |
Tgene | C0241210 | Speech Delay | 1 | CTD_human | |
Tgene | C0242379 | Malignant neoplasm of lung | 1 | CTD_human | |
Tgene | C0270612 | Leukoencephalopathy | 1 | CTD_human | |
Tgene | C0278996 | Malignant Head and Neck Neoplasm | 1 | CTD_human | |
Tgene | C0454655 | Semantic-Pragmatic Disorder | 1 | CTD_human | |
Tgene | C0678222 | Breast Carcinoma | 1 | CTD_human | |
Tgene | C0746787 | Cancer of Neck | 1 | CTD_human | |
Tgene | C0751177 | Cancer of Head | 1 | CTD_human | |
Tgene | C0751257 | Auditory Processing Disorder, Central | 1 | CTD_human | |
Tgene | C0887900 | Upper Aerodigestive Tract Neoplasms | 1 | CTD_human | |
Tgene | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human | |
Tgene | C1458155 | Mammary Neoplasms | 1 | CTD_human | |
Tgene | C1858991 | Childhood Ataxia with Central Nervous System Hypomyelinization | 1 | CTD_human | |
Tgene | C2239176 | Liver carcinoma | 1 | CTD_human | |
Tgene | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human | |
Tgene | C4721453 | Peripheral Nervous System Diseases | 1 | CTD_human |